$0.725
-0.006 (-0.86%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CNTB por análisis de gráficos similares
Alphio's CNTB stock price prediction model matches the current Connect Biopharma Holdings Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.73 (-0.04%). The 1-week path is $0.72 (-0.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Connect Biopharma Holdings Ltd?
Connect Biopharma Holdings Ltd is not a good buy right now due to its current price of $0.7771, which is significantly below its 52-week high of $3.82, indicating a steep decline of approximately 80%. The RSI of 28.565 suggests the stock is oversold, but the overall financial performance shows a troubling trend with a net income loss of $17,284,000 in the latest quarter. Furthermore, the forward P/E ratio of 0.7669 indicates potential undervaluation, but the company has not yet proven consistent revenue generation, with a year-to-date change of -69.16%. The main risk is the substantial net margin loss of -624.42% in the latest quarter, which raises concerns about the company's sustainability and ability to recover.
CNTB cerró en $0.73 el Friday, tras bajar -0.86%
Connect Biopharma Holdings Ltd (CNTB) last closed at $0.7254, losing -0.86%. These facts feed the 1-day and 1-week CNTB price prediction above.
Factores de la previsión
Los factores de la previsión de Connect Biopharma Holdings Ltd (CNTB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CNTB, ordenadas por similitud.
Análisis de estacionalidad de CNTB
Historically the probability of a positive November return for CNTB is 45.45%. April offers the highest probability of a positive month at 59.38%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CNTB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.62 | $1.85 | $2.19 | +155.37% |
| Dec 2026 | $1.53 | $1.56 | $1.88 | +114.71% |
En 2026, se proyecta que Connect Biopharma Holdings Ltd (CNTB) oscile entre $1.53 y $2.19.
Previsión mensual de Connect Biopharma Holdings Ltd para 2026
En Nov de 2026, se proyecta que Connect Biopharma Holdings Ltd promedie $1.85, con un mínimo de $1.62 y un máximo de $2.19.
En Dec de 2026, se proyecta que Connect Biopharma Holdings Ltd promedie $1.56, con un mínimo de $1.53 y un máximo de $1.88.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.